Quality of life in patients with HCV / HIV co-infection

Size: px
Start display at page:

Download "Quality of life in patients with HCV / HIV co-infection"

Transcription

1 Quality of life in patients with HCV / HIV co-infection Lyudmila Shostakovych-Koretskaya, MD, PhD 1, Olha Shevchenko-Makarenko, PhD 1, Lyudmila Timofeeva 2 1 Dnipropetrovsk Medical Academy, Department of infectious diseases, Dnipropetrovsk, Ukraine 2 Dnipropetrovsk municipal clinical hospital #21, AIDS center, Dnipropetrovsk, Ukraine dsmainfect@ukr.net

2 Epidemiological data of HIV infection in Dnipropetrovsk region (incidence, cases) Number of persons with newly diagnosed HIV infection Number of persons with newly diagnosed AIDS Number of people died of AIDS all including children INFORMATION BULLETIN HIV - 6 months Chuhalova I.; Kozina I. Dnepropetrovsk [ІНФОРМАЦІЙНИЙ БЮЛЛЕТЕНЬ ВІЛ-ІНФЕКЦІЯ 6 міс р. 73 зю Ukraine]. - Чухалова І.В.; Козіна І. м. Дніпропетровськ 2016 р. вих. 760/16 від

3 Epidemiological data of HIV infection in Dnipropetrovsk region According to data from July 1, 2016 in Dnepropetrovsk region 48,248 HIV-positive people had been registered (Prevalence of HIV-infection is cases per people). 16,929 people with AIDS (Prevalence of HIV infection is cases per people) and 8606 deaths from AIDS-related diseases. 25,533 patients with HIV infection are registered in HIV Center (Prevalence is cases per 100 thousand), incidence of AIDS is 7456 (229.3 cases per people). 10,715 patients receive antiretroviral therapy, including 550 children.

4 Epidemiological data of HCV infection in Dnipropetrovsk region, cases per people 35 31, ,99 11,58 18, ,48 11,5 16,6 15,8 13,62 HCV Dnepropetrovsk region HCV Ukraine Shevchenko-Makarenko O.P. Monitoring of incidence and prevalence of chronic viral hepatitis, experience of execution the National Programme for prevention, diagnosis and treatment of viral hepatitis in Dnipropetrovsk region / O.P. Shevchenko-Makarenko // Gepatologia (29). - S

5 Co-infection of HIV / hepatitis C in Dnipropetrovsk region In 2015 co-infection of HIV / hepatitis C in Dnipropetrovsk region was registered in 6327 people Of the surveyed HIV-infected patients in Dnipropetrovsk: in 2014 co-infection of HIV / hepatitis C was registered in 1451 people, including 6 children aged 0-18 years; and in 2015, due to migration and other factors, co-infection was registered in 1201 people and 8 children.

6 Health-related quality of life (HRQOL) is an integral characteristic of the physical, mental, emotional and social functioning of a person based on his subjective perception. (HRQOL) assessment is an important tool for effective management of patients with progressive chronic diseases. It is well known that the HRQOL is diminished in both groups of patients; with chronic HCV and HIV, but impact of HCV/ HIV coinfection on HRQOL is still not quite clear and is still not been sufficiently studied, especially among the Ukrainian population.

7 AIM Assess and compare the HRQOL of HIV infected patients with chronic HCV infection and with co-infection of HCV / HIV Identify the factors responsible for it

8 Materials & Methods: Study design - Cross-sectional study (3 groups) Group 1-57 patients with chronic HCV infection, Group 2-39 patients with co-infection of HCV / HIV. Group 3-30 healthy people - the control group. Study setting - Dnipropetrovsk municipal clinical hospital #21, AIDS center, Dnipropetrovsk, Ukraine. Nonrandom sampling Diagnosis established by local clinical protocols Ethical committee approval was taken Statistic 6,0 T-test was used to compare means. Study instruments - adapted HRQOL questionnaire SF-36 Health Status Survey, SF-36 contains 36 questions grouped in eight domains.

9 Sociodemographic data of the studied population (n=126) Inclusion criteria - >18 years Gender : male 77 female 49. Race: White Education : Elementary education - 0 Secondary education - 94 Tertiary education (university) 32 Martial status Married - 55 Single - 29 widow (-er) / divorced Age (mean±se, year): Group 1: chronic HCV infection 41,75±1,08 Group 2: co-infection of HCV / HIV 39,6±0,96 Group 3: Healthy control 22,03±0, male female male female male female control HCV HCV / HIV 17

10 Materials & Methods: Disease stage of HCV and HCV / HIV patients (n=96): Non-cirrhosis 76 Compensated cirrhosis (class A) 20 Decompensated cirrhosis - 0 Fibrosis of HCV and HCV / HIV patients (n=96): F0-10 F1-43 F2-11 F3 12 F4 20 Studies have been done before the start of HCV antiviral therapy For HCV / HIV patients (Group 2, n=39): CD4 258±32 cells/microl HIV RNA - negative All patients in this group were receiving ART

11 HRQOL scores in patients with HCV, HCV/ HIV and healthy controls (SF-36) (M±SE) control HCV HCV / HIV 20 0 PF RP BP GH VT SF RE MH PCS MCS (M±SD) control HCV HCV / HIV PF RP BP GH VT SF RE MH PCS MCS

12 Conclusions: Chronic hepatitis C and HCV/ HIV co-infection is a serious problem for patients. We found that the degree of physical health disturbance was more significant than the one of psychological health, especially in the group of co-infection of HIV / hepatitis C (p<0,05 for these indices as compared with the control group). Progressive liver disease significantly decreased QOL in both groups of patients: HCV and HCV/ HIV co-infection. QOL in all domains is lower in HCV/ HIV co-infected patients

ASSESSMENT OF QOL IN PATIENTS WITH PRADER WILLY SYNDROME

ASSESSMENT OF QOL IN PATIENTS WITH PRADER WILLY SYNDROME ASSESSMENT OF QOL IN PATIENTS WITH PRADER WILLY SYNDROME Aiming at investigating the relationship between QoL and clinical picture in patients with PWS, we conducted a multicentric study with prospective

More information

Validation of the Russian version of the Quality of Life-Rheumatoid Arthritis Scale (QOL-RA Scale)

Validation of the Russian version of the Quality of Life-Rheumatoid Arthritis Scale (QOL-RA Scale) Advances in Medical Sciences Vol. 54(1) 2009 pp 27-31 DOI: 10.2478/v10039-009-0012-9 Medical University of Bialystok, Poland Validation of the Russian version of the Quality of Life-Rheumatoid Arthritis

More information

Quality of life among type 2 diabetes patients in Udupi taluk: a cross-sectional study

Quality of life among type 2 diabetes patients in Udupi taluk: a cross-sectional study Research Article Quality of life among type 2 diabetes patients in Udupi taluk: a cross-sectional study Ravi Kant Singh 1, Sanjay Pattanshetty 1, Sreekumaran Nair 2 1 Department of Public Health, Manipal

More information

The North West Adelaide Health Study

The North West Adelaide Health Study North Diabetes can ruin your day Quality of life after diagnosis Catherine Chittleborough, Patrick Phillips, Maria Drakoulas, Katherine Baldock, Anne Taylor, & the North Team The North Biomedical cohort

More information

Glecaprevir-Pibrentasvir in HCV GT 1 or 4 & Prior DAA Treatment MAGELLAN-1 (Part 2)

Glecaprevir-Pibrentasvir in HCV GT 1 or 4 & Prior DAA Treatment MAGELLAN-1 (Part 2) Phase 3 Treatment-Experienced in HCV GT 1 or 4 & Prior DAA Treatment MAGELLAN-1 (Part 2) in HCV GT 1 or 4 & Prior DAA Treatment MAGELLAN-1 (Part 2): Study Features MAGELLAN-1 (Part 2) Trial Design: Randomized,

More information

The Chinese University of Hong Kong The Nethersole School of Nursing. CADENZA Training Programme

The Chinese University of Hong Kong The Nethersole School of Nursing. CADENZA Training Programme The Chinese University of Hong Kong The Nethersole School of Nursing CTP003 Chronic Disease Management and End-of-life Care Web-based Course for Professional Social and Health Care Workers Copyright 2012

More information

CURING HEPATITIS C IN GENERAL PRACTICE: THE FIRST 60 DAYS

CURING HEPATITIS C IN GENERAL PRACTICE: THE FIRST 60 DAYS CURING HEPATITIS C IN GENERAL PRACTICE: THE FIRST 60 DAYS Baker D 1,2, McMurchie M 1, Rodgers C 1, Farr V 1, Williams M 1 1 East Sydney Doctors, 2 Australasian Society for HIV Medicine 1 Disclosures Advisory

More information

infection: what is their quality of life?

infection: what is their quality of life? 682 Original Article Patients with chronic hepatitis B infection: what is their quality of life? Tan N C, Cheah S L, Teo E K, Yang L H ABSTRACT Introduction:Hepatitis B (HBV) is endemic in Singapore. This

More information

2017 UnitedHealthcare Services, Inc.

2017 UnitedHealthcare Services, Inc. UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 1146-7 Program Prior Authorization/Notification Medication Harvoni (ledipasvir/sofosbuvir) P&T Approval Date 10/2014, 2/2015,

More information

PP0214. Royal Perth Hospital, Perth, Australia; 2 Ramathibodi Hospital, Mahidol University, Bangkok, Thailand;

PP0214. Royal Perth Hospital, Perth, Australia; 2 Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; PP0214 Impact Of a 12-Week Oral Regimen of Elbasvir/Grazoprevir (EBR/GZR) On -related Quality of Life (HRQOL) and Fatigue In Treatment-Naïve Patients With Chronic Hepatitis C Virus (HCV) Genotype (GT)

More information

Hepatitis C Policy Discussion

Hepatitis C Policy Discussion Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

BVHG/BASL/BSG/BHIVA/BIA/CVN Guidelines for management of chronic HCV infection

BVHG/BASL/BSG/BHIVA/BIA/CVN Guidelines for management of chronic HCV infection BVHG/BASL/BSG/BHIVA/BIA/CVN Guidelines for management of chronic HCV infection Headline Recommendations 1. We recommend that NHSE considers commissioning pan-genotypic regimens for use in the community

More information

Reading** *Journal 吳孟玲. Presenter:Int. Outcome Evaluation of Surgical and Nonsurgical Management of Lumbar Disc Protrusion Causing Radiculopathy

Reading** *Journal 吳孟玲. Presenter:Int. Outcome Evaluation of Surgical and Nonsurgical Management of Lumbar Disc Protrusion Causing Radiculopathy *Journal Reading** Outcome Evaluation of Surgical and Nonsurgical Management of Lumbar Disc Protrusion Causing Radiculopathy 2007-06-26 Presenter:Int. 吳孟玲 Background lumbar disc protrusion causing radiculopathy

More information

LupusPRO (Lupus Patient Reported Outcome Tool) v1.7

LupusPRO (Lupus Patient Reported Outcome Tool) v1.7 LupusPRO (Lupus Patient Reported Outcome Tool) v1.7 Authors: Meenakshi Jolly and Simon Pickard For information on, or permission to use tool, please contact: Meenakshi Jolly, MD Assistant Professor of

More information

Health Related Quality of Life, Anxiety and Depression among Tuberculosis Patients in Kathmandu, Nepal Devkota J* 1,3, Devkota N 2, Lohani SP 1

Health Related Quality of Life, Anxiety and Depression among Tuberculosis Patients in Kathmandu, Nepal Devkota J* 1,3, Devkota N 2, Lohani SP 1 Research Article JMCJMS Health Related Quality of Life, Anxiety and Depression among Tuberculosis Patients in Kathmandu, Nepal Devkota J* 1,3, Devkota N 2, Lohani SP 1 Department of Public Health, Nobel

More information

HCV elimination : lessons from Scotland

HCV elimination : lessons from Scotland HCV elimination : lessons from Scotland Sharon Hutchinson Glasgow Caledonian University / Health Protection Scotland BHIVA Hepatology Highlights, Edinburgh, 17 th April 2018 Disclosures Honoraria from

More information

PEGINTRON (peginterferon alfa-2b) SECTION 1: Pegintron - Hepatitis C Monotherapy

PEGINTRON (peginterferon alfa-2b) SECTION 1: Pegintron - Hepatitis C Monotherapy SECTION 1: Hepatitis C Pegintron SECTION 2: Hepatitis C Pegintron & Ribavirin SECTION 3: Hepatitis C Pegintron, Ribavirin, & Sovaldi SECTION 4: Hepatitis C Pegintron, Ribavirin, & Olysio SECTION 1: Pegintron

More information

Addictions and the liver

Addictions and the liver Addictions and the liver John Logan Consultant t in Public Health Medicine i NHS Lanarkshire BBV Executive Lead Co-chair, Sexual Health & BBV Executive e Leads Group john.logan@lanarkshire.scot.nhs.uk

More information

2017 UnitedHealthcare Services, Inc.

2017 UnitedHealthcare Services, Inc. UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 2052-10 Program Prior Authorization/Medical Necessity Medication Harvoni (ledipasvir/sofosbuvir) P&T Approval Date 4/2015, 8/2015,

More information

Correspondence should be addressed to Maria Raikou;

Correspondence should be addressed to Maria Raikou; BioMed Research International, Article ID 274804, 9 pages http://dx.doi.org/10.1155/2014/274804 Research Article An Assessment of Health Related Quality of Life in a Male Prison Population in Greece Associations

More information

HIV/AIDS DEPARTMENT GLOBAL HEPATITIS PROGRAMME

HIV/AIDS DEPARTMENT GLOBAL HEPATITIS PROGRAMME HIV/AIDS DEPARTMENT GLOBAL HEPATITIS PROGRAMME Technical considerations and case definitions for VIRAL HEPATITIS SURVEILLANCE Dr Yvan J-F Hutin Global Hepatitis Programme 01 FOUR MAIN HEPATITIS VIRUSES

More information

COMPARISON OF QUALITY OF LIFE SCORES IN ADOLESCENTS WITH PRIMARY DYSMENORRHEA

COMPARISON OF QUALITY OF LIFE SCORES IN ADOLESCENTS WITH PRIMARY DYSMENORRHEA Original Article 13 COMPARISON OF QUALITY OF LIFE SCORES IN ADOLESCENTS WITH PRIMARY DYSMENORRHEA Kusuma Sriyakul 1, Somboon Kietinun 2, Junya Pattaraarchachai 2, Nijsiri Ruangrungsi 1,* 1 College of Public

More information

Interpretation Clinical significance: what does it mean?

Interpretation Clinical significance: what does it mean? Interpretation Clinical significance: what does it mean? Patrick Marquis, MD, MBA Mapi Values - Boston DIA workshop Assessing Treatment Impact Using PROs: Challenges in Study Design, Conduct and Analysis

More information

National Cancer Institute

National Cancer Institute Patient- reported outcome surveillance in older cancer survivors: Using the SEER-MHOS linked data resource Erin E. Kent, PhD Epidemiologist & Program Director Outcomes Research Branch Applied Research

More information

Civil Society Driven Response in Ukraine: A program making a difference and bringing results

Civil Society Driven Response in Ukraine: A program making a difference and bringing results Civil Society Driven Response in Ukraine: A program making a difference and bringing results CATIE Forum Making it work: From Planning to Practice October 16th, 2015 Andriy Klepikov International HIV/AIDS

More information

Tetiana Kyrychenko MD. Poltava Regional HIV/AIDS Prevention and Control Center. 4TH CEE MEETING ON VIRAL HEPATITIS AND HIV October 2018, Prague

Tetiana Kyrychenko MD. Poltava Regional HIV/AIDS Prevention and Control Center. 4TH CEE MEETING ON VIRAL HEPATITIS AND HIV October 2018, Prague Tetiana Kyrychenko MD Poltava Regional HIV/AIDS Prevention and Control Center 4TH CEE MEETING ON VIRAL HEPATITIS AND HIV 11-12 October 2018, Prague tanakyrychenko@gmail.com Disclosures No relevant conflicts

More information

Quality ID #435: Quality of Life Assessment For Patients With Primary Headache Disorders National Quality Strategy Domain: Effective Clinical Care

Quality ID #435: Quality of Life Assessment For Patients With Primary Headache Disorders National Quality Strategy Domain: Effective Clinical Care Quality ID #435: Quality of Life Assessment For Patients With Primary Headache Disorders National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

SECTION 1: OLYSIO with (PEGASYS) AND RIBAVIRIN SECTION 2: OLYSIO with (PEGINTRON) AND RIBAVIRIN RATIONALE FOR INCLUSION IN PA PROGRAM

SECTION 1: OLYSIO with (PEGASYS) AND RIBAVIRIN SECTION 2: OLYSIO with (PEGINTRON) AND RIBAVIRIN RATIONALE FOR INCLUSION IN PA PROGRAM SECTION 1: OLYSIO with (PEGASYS) AND RIBAVIRIN SECTION 2: OLYSIO with (PEGINTRON) AND RIBAVIRIN RATIONALE FOR INCLUSION IN PA PROGRAM SECTION 1: OLYSIO with (PEGASYS) AND RIBAVIRIN Background Hepatitis

More information

Integration of collaborative TB/HIV activities with harm reduction services

Integration of collaborative TB/HIV activities with harm reduction services Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases control, Head of Department on HIV/AIDS combating

More information

Alexandra Savova, Guenka Petrova. Medical University Sofia Faculty of Pharmacy

Alexandra Savova, Guenka Petrova. Medical University Sofia Faculty of Pharmacy Alexandra Savova, Guenka Petrova. Medical University Sofia Faculty of Pharmacy INTRODUCTION There are three basic goals laying down the therapeutic behavior during the treatment process of hepatitis infection:

More information

Intron A Hepatitis B. Intron A (interferon alfa-2b) Description

Intron A Hepatitis B. Intron A (interferon alfa-2b) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.01.01 Subject: Intron A Hepatitis B Page: 1 of 7 Last Review Date: November 30, 2018 Intron A Hepatitis

More information

Mortality from viral hepatitis in the Netherlands. S.W. Schalm & M.Toy. Dpts Gastroenterology Hepatology and Public Health Erasmus MC, Rotterdam, NL

Mortality from viral hepatitis in the Netherlands. S.W. Schalm & M.Toy. Dpts Gastroenterology Hepatology and Public Health Erasmus MC, Rotterdam, NL Mortality from viral hepatitis in the Netherlands S.W. Schalm & M.Toy Dpts Gastroenterology Hepatology and Public Health Erasmus MC, Rotterdam, NL Burden of disease: chronic viral hepatitis in NL annual

More information

Successful hepatitis C treatment lowers risk of death for people with HIV and HCV co infection

Successful hepatitis C treatment lowers risk of death for people with HIV and HCV co infection Successful hepatitis C treatment lowers risk of death for people with HIV and HCV co infection Liz Highleyman Produced in collaboration with hivandhepatitis.com Published: 28 October 2015 Jump to Trends

More information

Quality of life in patients with gastroesophageal reflux disease in an Iranian population

Quality of life in patients with gastroesophageal reflux disease in an Iranian population Gastroenterology and Hepatology From Bed to Bench. 2013 RIGLD, Research Institute for Gastroenterology and Liver Diseases ORIGINAL ARTICLE Quality of life in patients with gastroesophageal reflux disease

More information

Hepatitis C Policy Discussion

Hepatitis C Policy Discussion Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

continued TABLE E-1 Outlines of the HRQOL Scoring Systems

continued TABLE E-1 Outlines of the HRQOL Scoring Systems Page 1 of 10 TABLE E-1 Outlines of the HRQOL Scoring Systems System WOMAC 18 KSS 21 OKS 19 KSCR 22 AKSS 22 ISK 23 VAS 20 KOOS 24 SF-36 25,26, SF-12 27 Components 24 items measuring three subscales. Higher

More information

Length of Authorization: 8-16 weeks. Requires PA: All direct-acting antivirals for treatment of Hepatitis C. Approval Criteria

Length of Authorization: 8-16 weeks. Requires PA: All direct-acting antivirals for treatment of Hepatitis C. Approval Criteria Hepatitis C Direct-Acting Antivirals Goals: Approve use of cost-effective treatments supported by the medical evidence. Provide consistent patient evaluations across all hepatitis C treatments. Ensure

More information

Ying Liang 1* and Wei Wu 2

Ying Liang 1* and Wei Wu 2 Liang and Wu Health and Quality of Life Outcomes 204, 2:59 RESEARCH Open Access Exploratory analysis of health-related quality of life among the empty-nest elderly in rural China: An empirical study in

More information

Length of Authorization: 8-16 weeks. Requires PA: All direct-acting antivirals for treatment of Hepatitis C. Approval Criteria

Length of Authorization: 8-16 weeks. Requires PA: All direct-acting antivirals for treatment of Hepatitis C. Approval Criteria Hepatitis C Direct-Acting Antivirals Goals: Approve use of cost-effective treatments supported by the evidence. Provide consistent patient evaluations across all hepatitis C treatments. Ensure appropriate

More information

Is the standard SF-12 Health Survey valid and equivalent for a Chinese population? Citation Quality Of Life Research, 2005, v. 14 n. 2, p.

Is the standard SF-12 Health Survey valid and equivalent for a Chinese population? Citation Quality Of Life Research, 2005, v. 14 n. 2, p. Title Is the standard SF-12 Health Survey valid and equivalent for a Chinese population? Author(s) Lam, CLK; Tse, EYY; Gandek, B Citation Quality Of Life Research, 2005, v. 14 n. 2, p. 539-547 Issued Date

More information

Assessment of sofosbuvir (Sovaldi )

Assessment of sofosbuvir (Sovaldi ) Assessment of sofosbuvir (Sovaldi ) Summary of the national assessments of sofosbuvir (Sovaldi ) for the treatment of Hepatitis C December 18, 2014 Health Care Institute, Diemen, NL Lead Partner WP5 EUnetHTA

More information

SASKATCHEWAN FORMULARY BULLETIN Update to the 62nd Edition of the Saskatchewan Formulary

SASKATCHEWAN FORMULARY BULLETIN Update to the 62nd Edition of the Saskatchewan Formulary April 1, 2018 Bulletin #170 ISSN 1923-0761 SASKATCHEWAN FMULARY BULLETIN Update to the 62nd Edition of the Saskatchewan Formulary Related Information for Prescribers: The April 1, 2018 updates to existing

More information

The role of a Pharmacist in the analysis of adherence rates and associated factors in HIV-patients registered on Centralized Chronic Medicines

The role of a Pharmacist in the analysis of adherence rates and associated factors in HIV-patients registered on Centralized Chronic Medicines The role of a Pharmacist in the analysis of adherence rates and associated factors in HIV-patients registered on Centralized Chronic Medicines Dispensing and Distribution (CCMDD) programme in the public

More information

Professor Mark Nelson. Chelsea and Westminster Hospital, London, UK

Professor Mark Nelson. Chelsea and Westminster Hospital, London, UK Professor Mark Nelson Chelsea and Westminster Hospital, London, UK Treatment should be prioritized Treatment Indicated All naive and experienced pts with liver disease Prioritized Pts with fibrosis (F3)

More information

Epilepsy, co-morbidities and Quality of Life. Professor Gus A Baker PhD FBPS

Epilepsy, co-morbidities and Quality of Life. Professor Gus A Baker PhD FBPS Epilepsy, co-morbidities and Quality of Life Professor Gus A Baker PhD FBPS Gus A Baker 6/17/2013 1 Aims of Presentation What is Quality of life [QOL]? What do we know about the impact of epilepsy on QOL?

More information

DOES HEPATITIS D IN HBV/HIV CO-INFECTED PATIENTS AFFECT LIVER FUNCTION?

DOES HEPATITIS D IN HBV/HIV CO-INFECTED PATIENTS AFFECT LIVER FUNCTION? DOES HEPATITIS D IN HBV/HIV CO-INFECTED PATIENTS AFFECT LIVER FUNCTION? *Joanna Kozłowska, **Joanna Kubicka, *Joanna Jabłońska, *Tomasz Mikuła, **Ewa Siwak, ***Tomasz Dyda, *Alicja Wiercińska-Drapało *Hepatology

More information

SASKATCHEWAN FORMULARY BULLETIN Update to the 62nd Edition of the Saskatchewan Formulary

SASKATCHEWAN FORMULARY BULLETIN Update to the 62nd Edition of the Saskatchewan Formulary April 1, 2017 Bulletin #165 ISSN 1923-0761 SASKATCHEWAN FORMULARY BULLETIN Update to the 62nd Edition of the Saskatchewan Formulary Related Information for Prescribers: Only prescribers who have completed

More information

Concept of Measurement: RA Defining Decrements in Physical Function

Concept of Measurement: RA Defining Decrements in Physical Function Concept of Measurement: RA Defining Decrements in Physical Function Vibeke Strand, MD Biopharmaceutical Consultant Adjunct Clinical Professor, Division of Immunology, Stanford University Disclosures: Consultant

More information

How to treat HCV in HIV coinfection

How to treat HCV in HIV coinfection How to treat HCV in HIV coinfection Dr. med. Stefan Mauss Center for HIV and Hepatogastroenterology Duesseldorf, Germany These are real world cases from a rather wealthy social health care system off label

More information

Daklinza Sovaldi. Daklinza (daclatasvir) and Sovaldi (sofosbuvir) Description

Daklinza Sovaldi. Daklinza (daclatasvir) and Sovaldi (sofosbuvir) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Daklinza Sovaldi Page: 1 of 4 Last Review Date: September 18, 2015 Daklinza Sovaldi Description

More information

Daklinza Sovaldi. Daklinza (daclatasvir) and Sovaldi (sofosbuvir) Description

Daklinza Sovaldi. Daklinza (daclatasvir) and Sovaldi (sofosbuvir) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.01.36 Subject: Daklinza Page: 1 of 8 Last Review Date: March 18, 2016 Daklinza Description Daklinza (daclatasvir)

More information

EPIDEMIOLOGY, CLINICAL FEATURES AND OUTCOME OF ACUTE HEPATITIS C IN HIV-POSITIVE PATIENTS: PRESENTATION OF OUR EXPERIENCE

EPIDEMIOLOGY, CLINICAL FEATURES AND OUTCOME OF ACUTE HEPATITIS C IN HIV-POSITIVE PATIENTS: PRESENTATION OF OUR EXPERIENCE EPIDEMIOLOGY, CLINICAL FEATURES AND OUTCOME OF ACUTE HEPATITIS C IN HIV-POSITIVE PATIENTS: PRESENTATION OF OUR EXPERIENCE E. Angeli, A. Mainini, C. Atzori, G. Gubertini and G. Rizzardini II Dept. Infectious

More information

Considerations for Antiretroviral Use in Patients with Hepatitis B Virus & Human Immunodeficiency Syndrome Coinfection

Considerations for Antiretroviral Use in Patients with Hepatitis B Virus & Human Immunodeficiency Syndrome Coinfection Considerations for Antiretroviral Use in Patients with Hepatitis B Virus & Human Immunodeficiency Syndrome Coinfection Mahnaz Arian, MD Assistant Professor in infectious Disease Mashhad university of Medical

More information

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Thompson AJV; Expert panel representing the Gastroenterological

More information

Bible Class: Hepatitis B Virus Infection

Bible Class: Hepatitis B Virus Infection Bible Class: Hepatitis B Virus Infection Nasser Semmo UVCM, Hepatology What is the HBV prevalence? 2 Hepatitis B Worldwide approx. 350 Mio. chronically infected with HBV Approx. 40% of the world population:

More information

Effect of l-arginine on life quality in patients with hypertensive disease and chronic obstructive pulmonary disease

Effect of l-arginine on life quality in patients with hypertensive disease and chronic obstructive pulmonary disease 2017; 6(8): 109-113 ISSN (E): 2277-7695 ISSN (P): 2349-8242 NAAS Rating 2017: 5.03 TPI 2017; 6(8): 109-113 2017 TPI www.thepharmajournal.com Received: 19-06-2017 Accepted: 21-07-2017 Luybov Dron Iryna

More information

Section 7: Providing HCV testing and treatment to people who inject drugs

Section 7: Providing HCV testing and treatment to people who inject drugs Section 7: Providing HCV testing and treatment to people who inject drugs Dr. Niklas Luhmann (Médecins du Monde) Training Hepatitis C and HR for PWUD, 9 th -13 th May 2016, Hanoi, Vietnam Learning objective

More information

Second generation HIV surveillance: Better data for decision making

Second generation HIV surveillance: Better data for decision making Second generation HIV surveillance: Better data for decision making Prof Thomas M Rehle, MD, PhD Human Sciences Research Council, South Africa HAI Conference on Prevention and Control of the HIV Epidemic

More information

Validation of the SF-36 in patients with endometriosis

Validation of the SF-36 in patients with endometriosis Qual Life Res (2014) 23:103 117 DOI 10.1007/s11136-013-0442-5 Validation of the SF-36 in patients with endometriosis Donald E. Stull Radek Wasiak Noemi Kreif Mireia Raluy Antje Colligs Christian Seitz

More information

Update in hepatitis C virus infection

Update in hepatitis C virus infection Update in hepatitis C virus infection Eoin Feeney Consultant in Infectious Diseases St. Vincent s University Hospital Overview Natural history Diagnosis, screening, staging Management Barriers going forward

More information

Psychometric properties of the Chinese quality of life instrument (HK version) in Chinese and Western medicine primary care settings

Psychometric properties of the Chinese quality of life instrument (HK version) in Chinese and Western medicine primary care settings Qual Life Res (2012) 21:873 886 DOI 10.1007/s11136-011-9987-3 Psychometric properties of the Chinese quality of life instrument (HK version) in Chinese and Western medicine primary care settings Wendy

More information

Hepatitis C Genotype 1 (GT 1) Patients in the United States (US)

Hepatitis C Genotype 1 (GT 1) Patients in the United States (US) Hepatitis C Genotype 1 (GT 1) Patients in the United States (US) INDICATION is indicated with or without ribavirin for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1, 4, 5, or

More information

Length of Authorization: 8-16 weeks. Requires PA: All direct-acting antivirals for treatment of Hepatitis C. Approval Criteria

Length of Authorization: 8-16 weeks. Requires PA: All direct-acting antivirals for treatment of Hepatitis C. Approval Criteria Hepatitis C Direct-Acting Antivirals Goals: Approve use of cost-effective treatments supported by the evidence. Provide consistent patient evaluations across all hepatitis C treatments. Ensure appropriate

More information

Pegylated Interferons and Ribavirins

Pegylated Interferons and Ribavirins Pegylated Interferons and Ribavirins Goal(s): Cover drugs only for those clients where there is evidence of effectiveness and safety Length of Authorization: 16 weeks plus 12-36 additional weeks or 12

More information

Daklinza Sovaldi. Daklinza (daclatasvir) and Sovaldi (sofosbuvir) Description

Daklinza Sovaldi. Daklinza (daclatasvir) and Sovaldi (sofosbuvir) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Daklinza Sovaldi Page: 1 of 7 Last Review Date: June 24, 2016 Daklinza Sovaldi Description Daklinza

More information

Quality Of Life of Hypertensive Patients on Different Types of Antihypertensive Medications

Quality Of Life of Hypertensive Patients on Different Types of Antihypertensive Medications IOSR Journal Of Pharmacy (e)-issn: 2250-3013, (p)-issn: 2319-4219 www.iosrphr.org Volume 4, Issue 5 (May 2014), PP. 23-28 Quality Of Life of Hypertensive Patients on Different Types of Antihypertensive

More information

For any cancer and for infection-related cancer, immediate ART was associated with a lower cancer risk in the first three models but not in models D,

For any cancer and for infection-related cancer, immediate ART was associated with a lower cancer risk in the first three models but not in models D, Immediate ART in START Cuts Risk of Infection-Linked Cancer About 75% Conference on Retroviruses and Opportunistic Infections (CROI), February 22-25, 2016, Boston Mark Mascolini People who started antiretroviral

More information

Preliminary Results of an Evaluation of Ledipasvir/Sofosbuvir in Patients with Chronic HCV or HCV/HIV Co-Infection

Preliminary Results of an Evaluation of Ledipasvir/Sofosbuvir in Patients with Chronic HCV or HCV/HIV Co-Infection Preliminary Results of an Evaluation of Ledipasvir/Sofosbuvir in Patients with Chronic HCV or HCV/HIV Co-Infection Konstantin Zhdanov 1, Viacheslav Morozov 2, Elena A Orlova-Morozova 3, Riina Salupere

More information

Supplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups

Supplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups Supplemental Table S1: Unadjusted and Adjusted Hazard Ratios for Diabetes Associated with Baseline Factors Considered in Model 3 SMART Participants Only Unadjusted Adjusted* Baseline p-value p-value Covariate

More information

The impact of headache on quality of life

The impact of headache on quality of life J Headache Pain (2003) 4:S35 S41 Springer-Verlag 2003 INTANGIBLE COSTING Gisela M. Terwindt Michel D. Ferrari Lenore J. Launer The impact of headache on quality of life G.M. Terwindt ( ) M.D. Ferrari Department

More information

ijer.skums.ac.ir Health related quality of life in the female-headed households Received: 20/Apr/2015 Accepted: 6/Jul/2015

ijer.skums.ac.ir Health related quality of life in the female-headed households Received: 20/Apr/2015 Accepted: 6/Jul/2015 Original article International Journal of Epidemiologic Research, 2015; 2(4):178-183. ijer.skums.ac.ir Health related quality of life in the female-headed households Yousef Veisani 1,2, Ali Delpisheh 1,2*,

More information

System and Role of Pharmacovigilance in Implementing the Ukraine National TB Control Program

System and Role of Pharmacovigilance in Implementing the Ukraine National TB Control Program System and Role of Pharmacovigilance in Implementing the Ukraine National TB Control Program Irina Logvina Center for Drug Evaluation and Research, Ukrainian MH Antalya, Turkey December 10-13, 2013 Ukraine

More information

Length of Authorization: 8-12 weeks. Requires PA: All direct-acting antivirals for treatment of Hepatitis C. Approval Criteria

Length of Authorization: 8-12 weeks. Requires PA: All direct-acting antivirals for treatment of Hepatitis C. Approval Criteria Hepatitis C Direct-Acting Antivirals Goals: Approve use of cost-effective treatments supported by the medical evidence. Provide consistent patient evaluations across all hepatitis C treatments. Ensure

More information

Overlapping Epidemics:HIV/TB/IDU. Time for action! Sergey Filippovych, Associate Director: Treatment Olga Denisiuk Programme Officer : HIV/TB

Overlapping Epidemics:HIV/TB/IDU. Time for action! Sergey Filippovych, Associate Director: Treatment Olga Denisiuk Programme Officer : HIV/TB Overlapping Epidemics:HIV/TB/IDU. Time for action! Sergey Filippovych, Associate Director: Treatment Olga Denisiuk Programme Officer : HIV/TB 1 www.aidsalliance.org.ua Ukraine Ukraine: key context information:

More information

Kidney Transplantation in the Elderly. Kristian Heldal, MD, PhD Telemark Hospital Trust, Skien, Norway and University of Oslo

Kidney Transplantation in the Elderly. Kristian Heldal, MD, PhD Telemark Hospital Trust, Skien, Norway and University of Oslo Kidney Transplantation in the Elderly Kristian Heldal, MD, PhD Telemark Hospital Trust, Skien, Norway and University of Oslo Agenda Background: Age and chronic kidney disease End stage kidney disease:

More information

Meet the Professor: HIV/HCV Coinfection

Meet the Professor: HIV/HCV Coinfection Meet the Professor: HIV/HCV Coinfection Vincent Lo Re, MD, MSCE Assistant Professor of Medicine and Epidemiology Division of Infectious Diseases Center for Clinical Epidemiology and Biostatistics University

More information

PREVALENCE AND IMPACT OF PERIPHERAL NEUROPATHY ON QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS: PILOT STUDY

PREVALENCE AND IMPACT OF PERIPHERAL NEUROPATHY ON QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS: PILOT STUDY Trakia Journal of Sciences, Vol. 16, Suppl. 1, pp 71-76, 2018 Copyright 2018 Trakia University Available online at: http://www.uni-sz.bg ISSN 1313-3551 (online) doi:10.15547/tjs.2018.s.01.015 PREVALENCE

More information

Olysio PegIntron Ribavirin

Olysio PegIntron Ribavirin Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.01.27 Subject: Olysio PegIntron Ribavirin Page: 1 of 7 Last Review Date: March 18, 2016 Olysio PegIntron

More information

Olysio Pegasys Ribavirin

Olysio Pegasys Ribavirin Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.01.28 Subject: Olysio Pegasys Ribavirin Page: 1 of 7 Last Review Date: March 18, 2016 Olysio Pegasys

More information

Health-related quality of life (HRQOL) is widely

Health-related quality of life (HRQOL) is widely CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2006;4:187 195 Health-Related Quality of Life in Patients Attending a Gastroenterology Outpatient Clinic: Functional Disorders Versus Organic Diseases MAGNUS SIMRÉN,*

More information

Update on HIV-HCV Epidemiology and Natural History

Update on HIV-HCV Epidemiology and Natural History Update on HIV-HCV Epidemiology and Natural History Jennifer Price, MD Assistant Clinical Professor of Medicine University of California, San Francisco Learning Objectives Upon completion of this presentation,

More information

Science & Technologies ADVANCED TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C

Science & Technologies ADVANCED TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C ADVANCED TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C Gordana Panova 1,G. Shumanov 1,Hr. Stojanov 2, V. Zdravkova 1 B. Panova 2, S. Gazepov 1, N. Panov 2 Faculty of Medicine - University, GoceDelchev

More information

Prevalence and Impact of Hepatitis on the Quality of Life of Patients

Prevalence and Impact of Hepatitis on the Quality of Life of Patients Pardeep Mittal et al RESEARCH ARTICLE 10.5005/jp-journals-10018-1142 Prevalence and Impact of Hepatitis on the Quality of Life of Patients 1 Pardeep Mittal, 2 Prithpal S Matreja, 3 HK Rao, 2 PML Khanna

More information

Pegasys Ribavirin

Pegasys Ribavirin Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.01.08 Subsection: Anti-infective Agents Original Policy Date: January 1, 2006 Subject: Pegasys Ribavirin

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Patient Reported Outcome High Priority

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Patient Reported Outcome High Priority Quality ID #435: Quality of Life Assessment For Patients With Primary Headache Disorders National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Patient Reported Functional Outcomes

More information

Mental health changes in African American men following an exercise training study: (ARTIIS) Robert L. Newton, Jr., Ph.D.

Mental health changes in African American men following an exercise training study: (ARTIIS) Robert L. Newton, Jr., Ph.D. Mental health changes in African American men following an exercise training study: (ARTIIS) Robert L. Newton, Jr., Ph.D. Health benefits of exercise Plethora of studies showing mental health benefits

More information

The Association Between Comorbidities and Neurocognitive Impairment in Aging Veterans with HIV

The Association Between Comorbidities and Neurocognitive Impairment in Aging Veterans with HIV The Association Between Comorbidities and Neurocognitive Impairment in Aging Veterans with HIV Arianna Perra, P syd, Moira Dux, PhD Terry Lee- Wilk, PhD HIV and HCV in the VA VA is the largest provider

More information

Final Report. HOS/VA Comparison Project

Final Report. HOS/VA Comparison Project Final Report HOS/VA Comparison Project Part 2: Tests of Reliability and Validity at the Scale Level for the Medicare HOS MOS -SF-36 and the VA Veterans SF-36 Lewis E. Kazis, Austin F. Lee, Avron Spiro

More information

The HeartQol questionnaire. Reliability, validity and responsiveness?

The HeartQol questionnaire. Reliability, validity and responsiveness? The HeartQol questionnaire. Reliability, validity and responsiveness? Stefan Höfer, PhD, MSc Associate Professor Medical University Innsbruck The HeartQoL Story Data collection: 2000 2010 Presentations:

More information

The impact of depression and anxiety on quality of life in Chinese cancer patientfamily caregiver dyads, a cross-sectional study

The impact of depression and anxiety on quality of life in Chinese cancer patientfamily caregiver dyads, a cross-sectional study LI et al. Health and Quality of Life Outcomes (2018) 16:230 https://doi.org/10.1186/s12955-018-1051-3 RESEARCH Open Access The impact of depression and anxiety on quality of life in Chinese cancer patientfamily

More information

Assessment of health related quality of life in patients with hemifacial spasm

Assessment of health related quality of life in patients with hemifacial spasm International Journal of Advances in Medicine Singh PK et al. Int J Adv Med. 2016 Nov;3(4):893-897 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20163719

More information

Clinical Criteria for Hepatitis C (HCV) Therapy

Clinical Criteria for Hepatitis C (HCV) Therapy Clinical Criteria for Hepatitis C (HCV) Therapy Pre-Treatment Evaluation o Must have chronic hepatitis C and HCV genotype and sub-genotype documented; o Patients who have prior exposure to DAA therapy

More information

The Effect of Antiviral Therapy on Liver Fibrosis in CHC. Jidong Jia Beijing Friendship Hospital, Capital Medical University

The Effect of Antiviral Therapy on Liver Fibrosis in CHC. Jidong Jia Beijing Friendship Hospital, Capital Medical University The Effect of Antiviral Therapy on Liver Fibrosis in CHC Jidong Jia Beijing Friendship Hospital, Capital Medical University 2016-5-29 1 Disclosure Consultation for Abbvie, BMS, Gilead, MSD, Novartis and

More information

Catalyst for Change. Viral Hepatitis Control Program Country Model Ukraine. Zahedul Islam

Catalyst for Change. Viral Hepatitis Control Program Country Model Ukraine. Zahedul Islam Catalyst for Change Viral Hepatitis Control Program Country Model Ukraine Zahedul Islam Director: Treatment, Procurement & Supply Alliance for Public Health Ukraine Alliance for Public Health Alliance

More information

Dr Kate Childs. King s College Hospital NHS Foundation Trust, London THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014

Dr Kate Childs. King s College Hospital NHS Foundation Trust, London THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014 THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014 Dr Kate Childs King s College Hospital NHS Foundation Trust, London 1-4 April 2014, Arena and Convention Centre Liverpool Decrease in both IP-10 and 25(OH)D

More information

HIV Endgame II: Stopping the Syndemics that Drive HIV

HIV Endgame II: Stopping the Syndemics that Drive HIV Sean B. Rourke, Ph.D., FCAHS Scientific and Executive Director, OHTN Professor of Psychiatry, University of Toronto Director, CIHR Centre for REACH 2.0 in HIV/AIDS Director, CIHR Collaborative Centre for

More information

Viral Hepatitis. WHO Regional Office for Europe July 2013

Viral Hepatitis. WHO Regional Office for Europe July 2013 Viral Hepatitis WHO Regional Office for Europe July 2013 What is Hepatitis? Hepatitis is a viral infection that causes inflammation of the liver There are five main types of viral hepatitis: A, B, C, D,

More information

Journal of Patient- Reported Outcomes. Mary Kaye Willian 1, Geert D Haens 2, Aaron Yarlas 3* and Ashish V. Joshi 1

Journal of Patient- Reported Outcomes. Mary Kaye Willian 1, Geert D Haens 2, Aaron Yarlas 3* and Ashish V. Joshi 1 Willian et al. Journal of Patient-Reported Outcomes (2018) 2:22 https://doi.org/10.1186/s41687-018-0046-5 Journal of Patient- Reported Outcomes RESEARCH Open Access Changes in health-related quality of

More information

Targeting depression after ARDS. Neill Adhikari Sunnybrook Health Sciences and University of Toronto 29 October 2012

Targeting depression after ARDS. Neill Adhikari Sunnybrook Health Sciences and University of Toronto 29 October 2012 Targeting depression after ARDS Neill Adhikari Sunnybrook Health Sciences and University of Toronto 29 October 2012 None Conflicts of interest Objectives Review epidemiology of depression after ARDS Review

More information

Pegasys Pegintron Ribavirin

Pegasys Pegintron Ribavirin Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.01.47 Subsection: Anti-infective nts Original Policy Date: January 1, 2019 Subject: Pegasys Pegintron

More information